Form 4 for PRVA Privia Health Group, Inc.
Accepted 2024-05-31 00:00:00 ET · period of report 2024-05-29 · accession 0001759655-24-000103 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-05-31 | 2024-05-29 | PRVA | Boehler Adam | Dir | P - Purchase | $16.50 | +5,306 | 5.77M | +0.1% | +$87.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.01 par value per share | 2024-05-29 | P | A | 5,306 | $16.50 | 5,773,158 | I See footnote | — | — | (F1) Represents shares held or acquired by Puma Growth Holdings, LLC (Puma). Rubicon Founders OP GP, LP, of which the Reporting Person is the controlling General Partner, is the manager of Puma. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein, if any. (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.48 to $16.50 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |